Docusign (NASDAQ:DOCU - Get Free Report) was downgraded by stock analysts at Citigroup from a "buy" rating to a "neutral" rating in a report issued on Friday, Marketbeat.com reports. They currently have a $50.00 price target on the stock. Citigroup's target price would suggest a potential upside of 9.77% from the company's previous close.
Other equities analysts also recently issued research reports about the stock. Royal Bank Of Canada reduced their price objective on shares of Docusign from $70.00 to $55.00 and set a "sector perform" rating on the stock in a research note on Wednesday, March 18th. Wells Fargo & Company lowered their target price on shares of Docusign from $75.00 to $60.00 and set an "equal weight" rating for the company in a research note on Wednesday, March 18th. Morgan Stanley cut their price target on Docusign from $90.00 to $69.00 and set an "equal weight" rating for the company in a report on Wednesday, March 18th. Piper Sandler reduced their price target on Docusign from $75.00 to $52.00 and set a "neutral" rating on the stock in a research note on Wednesday, March 18th. Finally, Citizens Jmp lowered their price objective on Docusign from $124.00 to $86.00 and set a "market outperform" rating for the company in a research report on Wednesday, March 18th. Four investment analysts have rated the stock with a Buy rating, sixteen have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $61.40.
Check Out Our Latest Analysis on DOCU
Docusign Trading Down 0.4%
Docusign stock opened at $45.55 on Friday. The stock has a 50-day moving average price of $46.68 and a 200 day moving average price of $60.81. Docusign has a 52 week low of $40.16 and a 52 week high of $94.67. The stock has a market cap of $8.86 billion, a PE ratio of 30.78, a P/E/G ratio of 1.78 and a beta of 0.99.
Docusign (NASDAQ:DOCU - Get Free Report) last released its earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.95 by $0.06. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The company had revenue of $836.86 million for the quarter, compared to analyst estimates of $828.23 million. During the same period in the prior year, the firm earned $0.86 EPS. The firm's quarterly revenue was up 7.8% on a year-over-year basis. On average, equities analysts predict that Docusign will post 1.17 EPS for the current year.
Docusign declared that its board has authorized a stock repurchase plan on Tuesday, March 17th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to repurchase up to 21% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's board of directors believes its stock is undervalued.
Insider Buying and Selling at Docusign
In other Docusign news, CEO Allan C. Thygesen sold 26,250 shares of Docusign stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $47.78, for a total transaction of $1,254,225.00. Following the transaction, the chief executive officer directly owned 152,237 shares of the company's stock, valued at $7,273,883.86. The trade was a 14.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Robert Chatwani sold 16,696 shares of the business's stock in a transaction that occurred on Wednesday, March 18th. The stock was sold at an average price of $48.10, for a total transaction of $803,077.60. Following the sale, the insider owned 72,458 shares of the company's stock, valued at approximately $3,485,229.80. This represents a 18.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 64,673 shares of company stock worth $3,077,699. Company insiders own 1.01% of the company's stock.
Hedge Funds Weigh In On Docusign
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Rockefeller Capital Management L.P. raised its position in Docusign by 11.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 238,114 shares of the company's stock valued at $16,287,000 after purchasing an additional 24,842 shares during the period. Corient Private Wealth LLC boosted its position in shares of Docusign by 2.5% in the fourth quarter. Corient Private Wealth LLC now owns 29,608 shares of the company's stock worth $2,026,000 after buying an additional 732 shares during the period. Kera Capital Partners Inc. grew its stake in shares of Docusign by 347.8% in the fourth quarter. Kera Capital Partners Inc. now owns 16,556 shares of the company's stock valued at $1,132,000 after buying an additional 12,859 shares in the last quarter. Alberta Investment Management Corp grew its stake in shares of Docusign by 490.2% in the fourth quarter. Alberta Investment Management Corp now owns 72,000 shares of the company's stock valued at $4,925,000 after buying an additional 59,800 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV raised its holdings in shares of Docusign by 32.9% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 65,594 shares of the company's stock valued at $4,487,000 after buying an additional 16,250 shares during the period. Institutional investors and hedge funds own 77.64% of the company's stock.
Key Headlines Impacting Docusign
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Zacks Research raised a string of near‑ and medium‑term EPS forecasts (Q1‑2027, Q2‑2027, Q3‑2027, Q4‑2027 and FY2027 to $1.53 from $1.24) and boosted FY2028 to $1.89 (from $1.65) and issued FY2029 at $2.10 — signaling improved analyst profitability expectations that can support higher valuation.
- Positive Sentiment: DocuSign updated guidance for revenue: Q1‑2027 revenue guidance of $822.0M–$826.0M vs. a consensus ~$813.5M, and FY‑2027 revenue guidance of ~$3.5B vs. a ~$3.4B consensus. The topline beat potential helps explain upward pressure on the stock as it reduces near‑term execution risk.
- Positive Sentiment: Zacks also lifted several quarterly EPS views for 2028 (Q1, Q2, Q4) and Q3‑2027, reflecting improved visibility across multiple quarters rather than a single one-off revision — a constructive sign for forward earnings momentum.
- Neutral Sentiment: Increased investor attention and coverage pieces are circulating (Zacks summary of investor interest). Higher search/coverage can amplify moves but doesn’t itself change fundamentals. Investors Heavily Search Docusign Inc. (DOCU): Here is What You Need to Know
- Neutral Sentiment: Market retrospectives on Q4 results place DocuSign versus peers; useful context for sentiment but not new company-specific catalysts. A Look Back at Productivity Software Stocks’ Q4 Earnings: DocuSign Vs The Rest MSN recap
- Negative Sentiment: One small downside: Zacks trimmed its Q3‑2028 EPS view slightly (from $0.43 to $0.41). It’s a modest cut and currently outweighed by the larger set of upgrades, but investors tracking quarter‑by‑quarter trends may note increased dispersion in estimates.
Docusign Company Profile
(
Get Free Report)
DocuSign, Inc NASDAQ: DOCU is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report